Pancreatic cancer trials in Hong Kong

6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  Where

  Hksar, Shatin

  Age

  18 years and over

  People

  254 worldwide

  Run by

  Bristol-Myers Squibb

  See details and how to joinNCT07492680
• No phaseTaking people
  Determination of Pancreatic Steatosis Prevalence and Correlation With High-risk Cyst Features

  Where

  Shatin

  Age

  18 years and over

  People

  236

  Run by

  Chinese University of Hong Kong

  See details and how to joinNCT05334836
• No phaseTaking people
  Histotripsy x Pancreatic Cancer

  Where

  Hong Kong

  Age

  18 years and over

  People

  20

  Run by

  The University of Hong Kong

  See details and how to joinNCT07873606
• Phase 3Taking people
  Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  Where

  Hong Kong

  Age

  18 years and over

  People

  900 worldwide

  Run by

  Revolution Medicines, Inc.

  See details and how to joinNCT07491445 · EU 2025-525088-34-00
• No phaseTaking people
  Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer

  Where

  Hong Kong

  Age

  18 years and over

  People

  94

  Run by

  Chinese University of Hong Kong

  See details and how to joinNCT06160323
• No phaseTaking people
  EUS-guided RFA for Pancreatic Neoplasms

  Where

  Hong Kong

  Age

  18 years and over

  People

  30

  Run by

  Chinese University of Hong Kong

  See details and how to joinNCT03218345